Pharma channel feed

Lil­ly says to ‘take some cau­tion’ on oth­er com­pa­nies’ ear­ly-stage obe­si­ty da­ta, calls out com­pounders

9 months ago

FDA ap­proves Citius Phar­ma's non-Hodgkin lym­phoma drug Lym­phir

9 months ago
FDA+

Am­neal Phar­ma's ex­tend­ed-re­lease Park­ison's treat­ment clinch­es FDA ap­proval

9 months ago
FDA+

Q&A: PhRMA CEO Stephen Ubl on the IRA, chal­lenges to the FDA’s au­thor­i­ty and the US-Chi­na re­la­tion­ship

9 months ago
People

Lil­ly crush­es ex­pec­ta­tions with GLP-1 fran­chise, as sup­ply con­straints ease

9 months ago
Manufacturing

UK's NHS, Ver­tex strike pact, ac­cel­er­at­ing Cas­gevy roll­out in be­ta tha­lassemia

9 months ago

FDA ap­proves No­var­tis’ com­ple­ment in­hibitor Fab­hal­ta for rare kid­ney dis­ease

9 months ago
FDA+

Sarep­ta faces low­er rev­enue for Duchenne gene ther­a­py ahead of ex­pect­ed sales jump with ex­pand­ed treat­ment la­bel

9 months ago

FDA rep­ri­mands Bris­tol My­ers over mis­lead­ing ef­fi­ca­cy claims on Kraza­ti web­site

9 months ago
FDA+

UPenn sues BioN­Tech, says it owes 'sig­nif­i­can­t' Covid-re­lat­ed roy­al­ties

9 months ago
Law

Big drug­mak­ers have cut out­side R&D spend­ing amid broad pull­back, key con­trac­tor warns

9 months ago
Manufacturing

Pfiz­er got a $1.2B pay­out for its stake in Cerev­el

9 months ago
Deals

In­spec­tion de­lays hold back BeiGene's Tevim­bra progress once again

9 months ago
FDA+

Up­dat­ed: Madri­gal fi­nal­ly re­veals first wave of sales for MASH drug Rezd­if­fra

9 months ago
Marketing

No­vo Nordisk dou­bles US We­govy pre­scrip­tions as short­ages start to ease, but earn­ings fall be­low ex­pec­ta­tions 

9 months ago
Manufacturing

Up­dat­ed: No­vo Nordisk yanks We­govy fil­ing for heart fail­ure from FDA, will re­sub­mit next year

9 months ago
R&D

Up­dat­ed: Am­gen's Hori­zon buy­out pow­ers growth, with Mar­i­Tide plans in­tact

9 months ago

CDC chief says new RSV guid­ance was meant to be ‘clear’ and ‘ac­tion­able’

9 months ago
FDA+

No­vo Nordisk goes af­ter more com­pounders, ex­pand­ing GLP-1 law­suit cam­paign

9 months ago
Law

GSK wins sec­ond Zan­tac can­cer case to go to tri­al

9 months ago
Law

Hims takes steps to lock up drug sup­ply for its boom­ing weight loss busi­ness

9 months ago
Manufacturing
Health Tech

Genen­tech part­ners with cash-strapped Sang­amo on epi­ge­net­ic Alzheimer’s ther­a­py

9 months ago
Deals
R&D

Mer­ck en­lists part­ner Dai­ichi Sankyo to de­vel­op T cell en­gager from Har­poon ac­qui­si­tion

9 months ago
Deals

Bay­er de­tails 3,200 job cuts so far, spot­lights ‘mo­men­tum’ in phar­ma pipeline

9 months ago
First page Previous page 39404142434445 Next page Last page
A service from the Financial Times